Virbac S.A.
Virbac S.A. (VRBCF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VRBCF · as of Jun 9, 2026
Key Statistics
Explore Virbac S.A. Data
vrbcf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
vrbcf competitorsVRBCF
APNHF
BVNKF
BVNRY
GGNDF
GNNDYStock Performance
Full HistoryAbout Virbac S.A.
Virbac S.A. is a leading global animal health company that develops, produces, and distributes a comprehensive array of products and services designed for both domestic pets and livestock. The company…
what is virbac s.a. · vrbcf stock overview · virbac s.a. company profile · who is virbac s.a. ceo · vrbcf OTC · virbac s.a. headquarters · virbac s.a. business segments
About Stock Overview & Key Data
Virbac S.A. (VRBCF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Apr 17, 2013. As of the latest trading session, VRBCF stock price is $431.80, with a market capitalization of $3.6B. The stock has returned +24.80% over the past 12 months and +24.80% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Virbac S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Virbac S.A. reported revenue of $1.5B and net income of $150.8M. For detailed data — including Virbac S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Virbac S.A. (VRBCF) stock price is $431.80. The stock is traded on OTC under the ticker symbol VRBCF. The 52-week range is $346.00 – $431.80.